1. Future of the Cold Chain Industry Survey Results

    Previewing the results of Sonoco Thermosafe’s Future of the Cold Chain Industry survey, which will be fully released at the 12th Annual Cold Chain Global Forum in Boston, September 29-October 3.

  2. 2014 Guide to Global GDP Guidelines

    There is no single global GDP standard, this guide includes a map that highlights the latest national, regional and organizational guidelines, with links to the source documents. 

  3. Innovations In Purification: Lowering Cost And Accelerating Drug Development With Pre-Packed Columns For Single Use

    Monoclonal antibodies (mAbs) are becoming key therapeutic agents for treating complex diseases, such as rheumatoid arthritis and cancer, as well as niche and rare disorders. By Carol Preisig, Ph.D.

  4. New Requirements In Global Clinical Supply Spur Evolution And Innovation

    Who knew clinical trial logistics had so much in common with the automotive and high-tech industries? That certainly seems to be the case with trends like just-in-time (JIT), customer-managed inventory (CMI) and vendor-managed inventory (VMI).

  5. Continuous Biomanufacturing: 10 Reasons Sponsors Hesitate

    By William Whitford, Sr. Manager, HyClone Cell Culture, GE Healthcare

    The industry is abuzz with talk about continuous biomanufacturing (CB), and it virtues have been well described. Here we will look at some of the barriers or concerns perceived to limit its value to the industry. Justified or not, quite a few concerns have been expressed regarding the implementation of this new, rather disruptive technology. 

  6. BIOSTAT® RM and Flexsafe RM Brochure

    The BIOSTAT® RM, a fully GMP compliant, single-use, wave-mixed bioreactor and Flexsafe bags are proven for a broad range of different cell lines incl. CHO, NS0, SF9, E.coli and mesenchymal stem cells.

  7. BIOSTAT® RM 20/50 Basic

    stand-alone unit for benchtop use.

  8. BioPAT® Fundalux® Datasheet

    BioPAT® Fundalux – For online measurement of turbidity and total biomass in bacterial fermentation and mammalian cell cultures.

  9. BioPAT® SIMCA-Online

    Continuous real-time quality control and assurance is a highly desired state in biopharmaceutical manufacturing, which can be achieved by sophisticated process control strategies that use multivariate monitoring techniques to prevent or mitigate the risk of producing a poor quality product.

  10. BioPAT® SIMCA

    Multivariate Data Analysis (MVDA) techniques are being increasingly used for scale and batch-to-batch comparison investigations to support or derive process understanding and to ultimately improve the quality, safety and efficacy of a drug product.